4.8 Meeting Abstract

A FRENCH MULTICENTRIC LONGITUDINAL DESCRIPTIVE STUDY OF HEPATOCELLULAR CARCINOMA MANAGEMENT (THE CHANGH COHORT): PRELIMINARY RESULTS

Journal

JOURNAL OF HEPATOLOGY
Volume 52, Issue -, Pages S231-S232

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(10)60587-9

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

Marion Roux, Frederic Pigneur, Laurence Baranes, Julien Calderaro, Melanie Chiaradia, Thomas Decaens, Sandrine Kastahian, Anais Charles-Nelson, Lambros Tselikas, Charlotte Costentin, Alexis Laurent, Daniel Azoulay, Ariane Mallat, Alain Rahmouni, Alain Luciani

ABDOMINAL RADIOLOGY (2018)

Correction Radiology, Nuclear Medicine & Medical Imaging

Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? (vol 43, pg 1670, 2017)

Marion Roux, Frederic Pigneur, Laurence Baranes, Julien Calderaro, Melanie Chiaradia, Thomas Decaens, Sandrine Kastahian, Anais Charles-Nelson, Lambros Tselikas, Charlotte Costentin, Alexis Laurent, Daniel Azoulay, Ariane Mallat, Alain Rahmouni, Alain Luciani

ABDOMINAL RADIOLOGY (2018)

Article Oncology

Hepatocellular Carcinoma Is Diagnosed at a Later Stage in Alcoholic Patients: Results of a Prospective, Nationwide Study

Charlotte E. Costentin, Abbas Mourad, Pierre Lahmek, Xavier Causse, Alexandre Pariente, Herve Hagege, Anca Stela Dobrin, Claire Becker, Berangere Marks, Robert Bader, Bertrand Condat, Frederic Heluwaert, Jean Francois Seitz, Bruno Lesgourgues, Jacques Denis, Sylvie Deuffic-Burban, Isabelle Rosa, Thomas Decaens

CANCER (2018)

Article Gastroenterology & Hepatology

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance

Marianne Ziol, Nicolas Pote, Giuliana Amaddeo, Alexis Laurent, Jean-Charles Nault, Frederic Oberti, Charlotte Costentin, Sophie Michalak, Mohamed Bouattour, Claire Francoz, Georges Philippe Pageaux, Jeanne Ramos, Thomas Decaens, Alain Luciani, Boris Guiu, Valerie Vilgrain, Christophe Aube, Jonathan Derman, Cecile Charpy, Jessica Zucman-Rossi, Nathalie Barget, Olivier Seror, Nathalie Ganne-Carrie, Valerie Paradis, Julien Calderaro

HEPATOLOGY (2018)

Article Oncology

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

Lorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, Marc Pracht, Vittorina Zagonel, Philippe Mathurin, Elena Rota Caremoli, Camillo Porta, Bruno Daniele, Luigi Bolondi, Vincenzo Mazzaferro, William Harris, Nevena Damjanov, Davide Pastorelli, Maria Reig, Jennifer Knox, Francesca Negri, Jorg Trojan, Carlos Lopez Lopez, Nicola Personeni, Thomas Decaens, Marie Dupuy, Wolfgang Sieghart, Giovanni Abbadessa, Brian Schwartz, Maria Lamar, Terri Goldberg, Dale Shuster, Armando Santoro, Jordi Bruix

LANCET ONCOLOGY (2018)

Article Oncology

Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals

Zuzana Macek Jilkova, Arnaud Seigneurin, Celine Coppard, Laurissa Ouaguia, Caroline Aspord, Patrice N. Marche, Vincent Leroy, Thomas Decaens

CANCERS (2020)

Review Biochemistry & Molecular Biology

Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment

Mariam Mroweh, Gael Roth, Thomas Decaens, Patrice N. Marche, Herve Lerat, Zuzana Macek Jilkova

Summary: Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide, with its incidence on the rise. Chronic inflammation plays a key role in hepatocarcinogenesis, and inhibition of Akt has effects on both cancer cells and the tumor microenvironment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis

Gael S. Roth, Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Melodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrie, Lorraine Blaise, Olivier Sutter, Thomas Decaens, Jean-Charles Nault

Summary: Trans-arterial chemoembolization showed a significant increase in complete radiological response compared to bland embolization, but did not impact overall response or survival outcomes significantly. Both techniques had similar safety profiles in treating intermediate stage hepatocellular carcinoma.

CANCERS (2021)

Article Oncology

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model

Bleuenn Brusset, Jerome Dumortier, Daniel Cherqui, Georges-Philippe Pageaux, Emmanuel Boleslawski, Ludivine Chapron, Jean-Louis Quesada, Sylvie Radenne, Didier Samuel, Francis Navarro, Sebastien Dharancy, Thomas Decaens

Summary: The study compared the agreement for the criteria and outcomes of liver transplantation before and after the adoption of the AFP model, finding a longer waiting time and higher rate of bridging therapies after the AFP model was implemented, leading to poorer patient outcomes.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review

Lydie Carreres, Zuzana Macek Jilkova, Guillaume Vial, Patrice N. Marche, Thomas Decaens, Herve Lerat

Summary: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and research is focusing on decoding the molecular mechanisms behind it to identify new therapeutic targets. Reliable, simple, and reproducible tools are necessary for investigating these pathways, with animal models such as diet-induced NAFLD and NASH being developed to mimic the human disease. Rat models, specifically the dietary model of NAFLD and NASH, are being used to study different dietary compositions and their effects on liver pathogenesis.

BIOMEDICINES (2021)

Article Oncology

DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma

Keerthi Kurma, Olivier Manches, Florent Chuffart, Nathalie Sturm, Khaldoun Gharzeddine, Jianhui Zhang, Marion Mercey-Ressejac, Sophie Rousseaux, Arnaud Millet, Herve Lerat, Patrice N. Marche, Zuzana Macek Jilkova, Thomas Decaens

Summary: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, often associated with liver fibrosis or cirrhosis from chronic liver injuries. The liver's immune system plays a crucial role in disease progression towards HCC. The DEN-induced rat model of HCC exhibits molecular characteristics similar to human HCC, especially those with high proliferation, making it a valuable tool for preclinical testing.

CANCERS (2021)

Article Cell Biology

Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease

Zuzana Macek Jilkova, Marie Noelle Hilleret, Theophile Gerster, Nathalie Sturm, Marion Mercey-Ressejac, Jean-Pierre Zarski, Vincent Leroy, Patrice N. Marche, Charlotte Costentin, Thomas Decaens

Summary: This study found that ICM, especially PD-1 and 4-1BB, are overexpressed in liver tissue from AIH patients, and there is a strong correlation between the abundance of PD-1(+) CD8(+) T-cells and the severity of AIH (alanine transaminase and aspartate transaminase levels). This suggests that ICM play a significant role in disrupting immune homeostasis in the liver, indicating their potential as targets for therapeutic interventions.

CELLS (2021)

Article Cell Biology

Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma

Lydie Carreres, Marion Mercey-Ressejac, Keerthi Kurma, Julien Ghelfi, Carole Fournier, Olivier Manches, Florent Chuffart, Sophie Rousseaux, Melanie Minoves, Thomas Decaens, Herve Lerat, Zuzana Macek Jilkova

Summary: This study investigated the impact of OSA-related chronic intermittent hypoxia on HCC progression using a HCC model. The study found that intermittent hypoxia further increased HCC cell proliferation, potentially contributing to an increased risk of HCC progression.

CELLS (2022)

Article Biochemistry & Molecular Biology

Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model

Keerthi Kurma, Ayca Zeybek Kuyucu, Gael S. Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N. Marche, Thomas Decaens, Zuzana Macek Jilkova

Summary: The study demonstrates that vevorisertib, an allosteric AKT inhibitor, effectively suppresses tumor progression and improves liver fibrosis in a hepatocellular carcinoma (HCC) rat model. The combination of vevorisertib with sorafenib shows significant reduction in tumor growth compared to the control group. These findings provide a rationale for clinical testing of vevorisertib and highlight the importance of targeting AKT in HCC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection

Laurissa Ouaguia, Vincent Leroy, Tania Dufeu-Duchesne, David Durantel, Thomas Decaens, Margaux Hubert, Jenny Valladeau-Guilemond, Nathalie Bendriss-Vermare, Laurence Chaperot, Caroline Aspord

FRONTIERS IN IMMUNOLOGY (2019)

No Data Available